Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
3.850
+0.280 (7.84%)
At close: Nov 20, 2024, 4:00 PM
3.640
-0.210 (-5.45%)
After-hours: Nov 20, 2024, 7:21 PM EST
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $2.24 million as of November 21, 2024. Its market cap has increased by 31.54% in one year.
Market Cap
2.24M
Enterprise Value
-3.67M
1-Year Change
31.54%
Ranking
Category
Stock Price
$3.85
Market Cap Chart
Since December 7, 2015, Biodexa Pharmaceuticals's market cap has decreased from $492.00M to $2.24M, a decrease of -99.55%. That is a compound annual growth rate of -45.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.30M | -31.58% |
| Dec 29, 2023 | 1.90M | -51.28% |
| Dec 30, 2022 | 3.90M | -70.45% |
| Dec 31, 2021 | 13.20M | 29.41% |
| Dec 31, 2020 | 10.20M | 21.43% |
| Dec 31, 2019 | 8.40M | -55.56% |
| Dec 31, 2018 | 18.90M | -76.84% |
| Dec 29, 2017 | 81.60M | -55.82% |
| Dec 30, 2016 | 184.70M | -43.10% |
| Dec 31, 2015 | 324.60M | -34.02% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 180 Life Sciences | 2.37M |
| HeartSciences | 2.35M |
| PainReform | 2.33M |
| Xylo Technologies | 2.30M |
| Venus Concept | 2.19M |
| Phio Pharmaceuticals | 2.14M |
| Scorpius Holdings | 2.09M |
| Salarius Pharmaceuticals | 2.07M |